A PK, Safety and Tolerability Study of Peripheral and Central Infusion of Melflufen in RRMM Patients
Clinical trial NCT04412707 · TERMINATED
Trial details
- NCT number
- NCT04412707
- Sponsor
- Oncopeptides AB
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-08-04
- Primary completion
- 2021-06-02
- Enrollment
- 27
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.